Back to
PRICE T ROWE ASSOCIATES INC /MD/EIEIKN
EIEIKN2 quarters
Position history for
PRICE T ROWE ASSOCIATES INC /MD/'s holdings in EIKON THERAPEUTICS INC
Yes. Price T Rowe Associates holds 1,005,035 shares of EIKN (Eikon Therapeutics), worth $13.1M, as of its Q2 2026 13F filing. It increased the position by 29,201 shares (+3.0%) from Q1 2026. Price T Rowe Associates has held EIKN since Q1 2026, across 2 quarterly 13F filings.
Current Value
$13.1M
Current Shares
1M
Total Value Change
+$2.8M
Total Shares Change
+29,201
Quarter-by-Quarter History
Other major holders of EIKN: FMR LLC, BlackRock, Inc., Capital World Investors